Effect of omalizumab on patients with chronic urticaria

Annals of Allergy, Asthma and Immunology

Volumn 99, Issue 2, 2007, Pages 190-193

  Spector, Sheldon L ^a,b   Tan, Ricardo A ^b  

^a UCLA MEDICAL CENTER   (United States)

^b California Allergy and Asthma Medical Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ANTIHISTAMINIC AGENT; CETIRIZINE; DESLORATADINE; DOXEPIN; ETHINYLESTRADIOL; ETYNODIOL DIACETATE; FEXOFENADINE; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN E ANTIBODY; IMMUNOGLOBULIN E RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; LORATADINE; MESALAZINE; MONTELUKAST; OMALIZUMAB; RANITIDINE; SERTRALINE; STEROID; TERBUTALINE; ZILEUTON;

ADULT; ARTICLE; AUTOIMMUNITY; CASE REPORT; CHRONIC URTICARIA; CLINICAL FEATURE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SUBSTITUTION; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; MALE; PATHOGENESIS; PRESCRIPTION; PRIORITY JOURNAL; SYSTEMIC THERAPY; TREATMENT OUTCOME; TREATMENT RESPONSE;

EID: 34547944181     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60644-8     Document Type: Article

References (14)

1. Spector SL, Tan RA. Antileukotrienes in chronic urticaria. J Allergy Clin Immunol. 1998;101:572.
2. Greaves M. Chronic urticaria. J Allergy Clin Immunol. 2000; 105:664-672.
3. Gruber BL, Baeza M, Marchese M, et al. Prevalence and functional role of anti-IgE autoantibodies in urticarial syndromes. J Invest Dermatol. 1988;90:213-217.
4. Hide M, Francis DM, Grattan CE, et al. Autoantibodies against the high-affinity IgE receptor as a cause of histamine release in chronic urticaria. N Engl J Med. 1993;328:1599-1604.
5. Grattan CEH, Hamon CGB, Cowan MA, et al. Preliminary identification of a low molecular weight serological mediator in chronic idiopathic urticaria. Br J Dermatol. 1998;119:179-184.
6. Ferrer M, Nakazawa K, Kaplan AP. Complement dependence of histamine release in chronic urticaria. J Allergy Clin Immunol. 1999;104:169-172.
7. Yasnowsky KM, Dreskin SC, Efaw B, et al. Chronic urticaria sera increase basophil CD203c expression. J Allergy Clin Immunol. 2006;117:1430-1434.
8. Kikuchi Y, Kaplan AP. Mechanisms of autoimmune activation of basophils in chronic urticaria. J Allergy Clin Immunol. 2001; 107:1056-1062.
9. Boyce JA. Successful treatment of cold-induced urticaria/ anaphylaxis with anti-IgE. J Allergy Clin Immunol. 2006;117: 1415-1418.
10. Strunk RC, Bloomberg GR. Omalizumab for asthma. N Engl J Med. 2006;354:2689-2695.
11. Beck LA, Marcotte GV, MacGlashan D, Togias A, et al. Omalizumab-induced reductions in mast cell Fcepsilon RI expression and function. J Allergy Clin Immunol. 2004;114:527-530.
12. Kaplan AP. Chronic urticaria: pathogenesis and treatment. J Allergy Clin Immunol. 2004;114:465-474.
13. Poon E, Seed PT, Greaves MW, Kobza-Black A. The extent and nature of disability in different urticarial conditions. Br J Dermatol. 1999;140:667-671.
14. O'Donnell BF, Lawlor F, Simpson J, Morgan M, Greaves MW. The impact of chronic urticaria on the quality of life. Br J Dermatol. 1997;136:197-201.